Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

IMA402, an Off-the-Shelf, Next-Generation TCR Bispecific (TCER®) for Efficiently Targeting an HLA-Presented Peptide from the Pan-Cancer Antigen PRAME

Sebastian Bunk, Martin Hofmann, Gabriele Pszolla, Meike Hutt, Frank Schwöbel, Felix Unverdorben, Nadine Aschmoneit, Claudia Wagner, Maike Jaworski, Heiko Schuster, Florian Schwoerer, Christoph Schraeder, Oliver Schoor, Sarah Missel, Toni Weinschenk, Dominik Maurer, Carsten Reinhardt

Blood (2022) 140 (Supplement 1): 9089–9090.

https://doi.org/10.1182/blood-2022-165937

Published: 2022

Journal Articles

Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER ® ) Molecules

Sebastian Bunk, PhD, Martin Hofmann, PhD, Felix Unverdorben, PhD, Meike Hutt, PhD, Gabriele Pszolla, PhD, Frank Schwöbel, PhD, Claudia Wagner, PhD, Sara Yousef, PhD, Heiko Schuster, PhD, Sarah Missel, PhD, Oliver Schoor, PhD, Toni Weinschenk, PhD, Harpreet Singh-Jasuja, PhD, Dominik Maurer, PhD, Carsten Reinhardt, MD

Blood (2019) 134 (Supplement_1): 3368.

https://doi.org/10.1182/blood-2019-129958

Published: 2019

Journal Articles

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

Madeleine M. Hipp, Norbert Hilf, Steffen Walter, Daniela Werth, Katharina M. Brauer, Markus P. Radsak, Toni Weinschenk, Harpreet Singh-Jasuja, Peter Brossart

Blood (2008) 111 (12): 5610–5620.

https://doi.org/10.1182/blood-2007-02-075945

Published: 2008

Includes: Supplemental data

Journal Articles

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Cristina N. Boß, Frank Grünebach, PhD, Katharina M. Brauer, Toni Weinschenk, PhD, Lothar Kanz, MD, Stefan Stevanovic, PhD, Hans-Georg Rammensee, PhD, Peter Brossart, MD

Blood (2006) 108 (11): 3703.

https://doi.org/10.1182/blood.V108.11.3703.3703

Published: 2006

Journal Articles

The Effects of Imatinib on the Function of Monocyte Derived Dendritic Cells Are Mediated Via the Inhibition of Akt and NF-kappaB Signal Transduction Pathways.

Anette Rupf, MB, Silke Appel, PhD, Markus M. Weck, MS, Frank Grünebach, PhD, Lothar Kanz, MD, Oliver Schoor, MS, Tim H. Brümmendorf, MD, Toni Weinschenk, PhD, Peter Brossart, MD

Blood (2004) 104 (11): 3453.

https://doi.org/10.1182/blood.V104.11.3453.3453

Published: 2004

NARROW

IMA402, an Off-the-Shelf, Next-Generation TCR Bispecific (TCER®) for Efficiently Targeting an HLA-Presented Peptide from the Pan-Cancer Antigen PRAME

Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER ® ) Molecules

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

The Effects of Imatinib on the Function of Monocyte Derived Dendritic Cells Are Mediated Via the Inhibition of Akt and NF-kappaB Signal Transduction Pathways.

Email alerts

ASH Publications

American Society of Hematology

IMA402, an Off-the-Shelf, Next-Generation TCR Bispecific (TCER®) for Efficiently Targeting an HLA-Presented Peptide from the Pan-Cancer Antigen PRAME

Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER ® ) Molecules

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

The Effects of Imatinib on the Function of Monocyte Derived Dendritic Cells Are Mediated Via the Inhibition of Akt and NF-kappaB Signal Transduction Pathways.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only